Search

everythinglearnresearchcommunity

for

Search:↓

A woman with non-classic CAH had unusual heavy periods and high hormone levels, improved with treatment.

The patient's long-term symptoms were due to Sheehan's syndrome, which improved with hormone therapy.

Early physical exams are crucial for timely Klinefelter syndrome diagnosis.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

GnRH analogues are effective for diagnosing and treating female androgen excess, offering a non-surgical option.

Clinical signs of excess male hormones and actual hormone levels in the blood do not always match in women with polycystic ovary syndrome.

A 22-year-old woman with a rare genetic condition was successfully treated to develop normal female characteristics and regular menstruation.

A 68-year-old woman developed male traits due to a tumor in her ovary, which was removed, returning her hormone levels to normal.

Elderly patients with frailty should be checked for hypopituitarism, as treatment can greatly improve their health and lifespan.

A woman's excessive hair growth and high testosterone were caused by a rare ovarian tumor, which was successfully treated with surgery.

Masculinizing hormone therapy increases the risk of hair loss in transgender and gender-diverse patients.

Removing the ovaries can help treat hair loss caused by high androgen levels in postmenopausal women.

Growth hormone therapy boosts androgen effects on skin in men.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

New genes and pathways are important for testosterone production and male sexual development.

A young girl with high testosterone was thought to have a tumor but actually had PCOS, which was treated with birth control pills.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

Hypothyroidism may worsen metabolic problems like insulin resistance and obesity in women with PCOS.

Late diagnosis of congenital adrenal hyperplasia can greatly affect physical development, gender identity, and sexual health.

Transgender patients on masculinizing hormones have higher hair loss rates than cisgender women.

A 17-year-old female with adrenogenital syndrome produces very high levels of androgens, which prevent complete feminization despite high estrogen doses.

A 36-year-old person with a female appearance but male chromosomes was diagnosed with a rare enzyme deficiency affecting sexual development.

The GH-IGF-I axis is likely involved in the hormonal imbalances seen in non-obese women with functional hyperandrogenism.

The therapies improved ejaculation disorders and sexual function in middle-aged men.

A postmenopausal woman's virilization was caused by a rare ovarian tumor that was hard to detect but was successfully treated with surgery.

Young men with early baldness may have lower Luteinizing Hormone levels due to higher dihydrotestosterone, possibly from certain drugs or gland disorders.

A 63-year-old woman's male-like symptoms were caused by a rare testosterone-producing ovarian tumor, treated by removing her ovaries and fallopian tubes.

Most 46XX CAH patients have female identity, but a few identify as male and may need treatment and surgery.

Blood tests are needed to confirm high male hormone levels in women with PCOS, as physical signs alone are not reliable.